Themis Medicare Limited engages in the manufacture and marketing of pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients. The company also provides formulations in dosage forms in the areas of anti tuberculosis, anti malarial, anesthetics, anti infective, anti hemorrhoid, pain management, anti osteoporotic, nutritional supplement, and haemostatic agents. In addition, it offers oral solids and liquids, injectables, and topical preparations in various areas, such as analgesics and anti-inflammatory agents, anthelmintic, anti-allergic, antianginals, anti-cold and cough, antidiarrheal, anti-infective, antifungals, antimalarials, antioxidants, antiplatelet agents, anti-TB drugs, anxiolytics, calcium preparations, erectile dysfunction medication, H2 receptor blockers and their combinations, haemostatic agents, muscle relaxants, NSAIDs, protein preparations, proton pump inhibitors and their combinations, statins, vitamins, alkalizer, antipyretic agents, antispasmodics, digestive enzymes, hematinics, antiemetic and antinauseants, corticosteroids, methylcobalamin, uterine stimulant, antiacne, and wound care. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1969 and is headquartered in Mumbai, India.